Is Alzamend Neuro, Inc. (ALZN) the Cheapest Stock Insiders Are Buying In March? - Yahoo Finance
4 weeks ago • Google News
Alzamend Neuro Inc (ALZN)
US$ 1.49-0.67%
Price Chart
Key Statistics
Market Cap
$ 4.52M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
83.53K
52W High
$ 7.80
52W Low
$ 0.64
Dividend Yield
0.00%
Beta
-0.19
Technicals
50-Day MA
0.8868
200-Day MA
1.6948
52 Week High
7.8
52 Week Low
0.643
About ALZN
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
Employees
4
Headquarters
Atlanta, GA
CEO
Mr. Stephan Jackman
Latest News
Alzamend Neuro (ALZN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - Nasdaq
3 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg